These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15753523)

  • 21. Continuing: Biology of cachexia.
    Bozzetti F
    J Natl Cancer Inst; 1999 Jun; 91(12):1077; author reply 1077-8. PubMed ID: 10379972
    [No Abstract]   [Full Text] [Related]  

  • 22. Thalidomide attenuates tumor growth and preserves fast-twitch skeletal muscle fibers in cholangiocarcinoma rats.
    Liu KH; Liao LM; Ro LS; Wu YL; Yeh TS
    Surgery; 2008 Mar; 143(3):375-83. PubMed ID: 18291259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide--a treatment for cancer?
    Mayo Clin Health Lett; 2000 Jun; 18(6):4. PubMed ID: 10868128
    [No Abstract]   [Full Text] [Related]  

  • 24. Thalidomide shows promise as cancer treatment.
    Health News; 2000 Jan; 6(1):8. PubMed ID: 11019665
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of extensive infantile hemangiomatosis of the small bowel in a 3-month-old with thalidomide and somatostatin analog.
    Jarvi K; Roebuck DJ; Sebire NJ; Lindley K; Shah N; Salomon J; Curry JI
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):593-7. PubMed ID: 18493217
    [No Abstract]   [Full Text] [Related]  

  • 26. [The molecular bases of the cachexia associated with cancer].
    Argilés JM; López Soriano FJ
    Med Clin (Barc); 1990 Jan; 94(1):18-20. PubMed ID: 2186226
    [No Abstract]   [Full Text] [Related]  

  • 27. Thalidomide. A surprising recovery.
    Stirling D; Sherman M; Strauss S
    J Am Pharm Assoc (Wash); 1997; NS37(3):306-13. PubMed ID: 9170807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multisite studies offer a solution to recruitment challenges in palliative care studies.
    Ritchie CS; Currow DC; Abernethy AP; Kutner JS
    J Palliat Med; 2013 Mar; 16(3):225. PubMed ID: 23437832
    [No Abstract]   [Full Text] [Related]  

  • 29. Thalidomide in primary peritoneal mesothelioma.
    Biswas G; Narayanan P; Bhagwat R; Khadwal A; Bakshi AV; Parikh PM
    J Surg Oncol; 2006 Apr; 93(5):434. PubMed ID: 16550583
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thalidomide: (re)discovery of a not very dear old molecule].
    Bressoud A; Schwab BZ
    Rev Med Suisse Romande; 2003 Apr; 123(4):238-40. PubMed ID: 15088555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials referral resource. Current clinical trials of thalidomide.
    Streicher HZ; Vereshchagina LA; Schoenfeldt M
    Oncology (Williston Park); 2003 Mar; 17(3):369-71, 374-5, 379-80. PubMed ID: 12661268
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticytokine approaches to the treatment of anorexia and cachexia.
    Haslett PA
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):53-7. PubMed ID: 9625384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of thalidomide in androgen-independent prostate cancer.
    Cox MC; Dahut WL; Figg WD
    Urol Oncol; 2006; 24(3):246-9. PubMed ID: 16678058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of angiogenesis: thalidomide or low-molecular-weight heparin?
    Ozkan M; Eser B; Er O; Dogu GG; Altinbas M
    J Clin Oncol; 2005 Mar; 23(9):2113; author reply 2113-4. PubMed ID: 15774812
    [No Abstract]   [Full Text] [Related]  

  • 35. Thalidomide: from teratogen to anti-angiogenic.
    Grover JK; Vats K
    Indian J Cancer; 2001 Mar; 38(1):22-32. PubMed ID: 14758882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.
    Rajkumar SV; Witzig TE
    Cancer Treat Rev; 2000 Oct; 26(5):351-62. PubMed ID: 11006136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignancy. Cancer cachexia.
    Calman KC
    Br J Hosp Med; 1982 Jan; 27(1):28-9, 33-4. PubMed ID: 6800431
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.
    Ribatti D; Vacca A
    Leukemia; 2005 Sep; 19(9):1525-31. PubMed ID: 15973447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide and wasting.
    Posit Aware; 1995; VI(6):5. PubMed ID: 11363147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokines and cancer anorexia cachexia syndrome.
    Bennani-Baiti N; Davis MP
    Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.